Polypeptide Therapeutic Solutions acquired by Arcline Investment

Polypeptide Therapeutic Solutions acquired by Arcline Investment

Arcline Investment Management has acquired Polypeptide Therapeutic Solutions (PTS), a Spanish manufacturer of polyaminoacid-based drug delivery systems, from Columbus Venture Partners. The financial terms of the deal were not disclosed by the parties. Polypeptide Therapeutic Solutions is engaged in manufacturing polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications, which include mRNA, DNA, […]

Aura Biosciences raises $80m for VDC therapies for cancers

Aura Biosciences raises $80m for VDC therapies for cancers

Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies for multiple oncology indications. The funding round of the US-based clinical-stage oncology company was led by Matrix Capital Management and Surveyor Capital, a Citadel company. New investors such as Rock […]